Introduction
Asthma is a global health problem and afflicted 334 million people worldwide in 2014. 1 It is more pronounced in parts of Asia, with 107 million sufferers in Southeast Asia and Western Pacific Region. 2, 3 Asthma also presents an economic cost: directly from hospitalization, treatment, and health care resources and indirectly from time lost from work, absenteeism, and premature death. In 2006, annual per patient direct cost of treatment ranged from USD108 to USD1,010 and constituted about 13.0% of the per capita GDP of countries in the Asia-Pacific. 4 The cost of uncontrolled asthma was estimated to be 1.51 times that of the controlled disease 4 and highlighted the need for better disease management if countries were to rein in the burden of caring for asthma patients.
The 2012 REcognise Asthma and LInk to Symptoms and Experience (REALISE) survey was the largest appraisal of asthma patients in Europe. 5 It showed that asthma control remained poor, and many patients perceived their asthma to be controlled and not serious despite the presence of symptoms and exacerbations. Furthermore, the optimal levels of asthma control achieved in clinical studies were often not replicated in real-life studies. 6 Real-life studies revealed that asthma control when assessed according to international guidelines, such as the Global Initiative for Asthma (GINA), 7 was poor, and this was attributed to a complex interaction of guidelines and disease-, patient-, and doctor-related factors. Many patients felt least informed about the meaning of asthma control. 6 While the overall prevalence of asthma in the Asian adult population (,5%) was lower than that in European populations, temporal studies of asthma prevalence in several developed Asian countries revealed a rising trend. 8 Asthma control in Asia remained low despite the availability of efficacious treatments. Earlier Asian studies of asthma patients were conducted through face-to-face or phone interviews and mainly addressed the burden of disease and patient's reactions to exacerbations. [9] [10] [11] Where available, results showed that patients often overestimated their level of control and the situation has not improved in recent years. 9 Earlier studies, including REALISE, used guidelines such as GINA to determine the level of control and did not seek the patient's view of asthma control. This study, REALISE Asia, focused on patients' perceptions of asthma control and their attitudes toward the disease and its treatment in an accessible, reallife adult Asian population. It used an online survey to seek eligible respondents from validated consumer panels who used social media to broaden the coverage and reach to the patients.
Materials and methods study design
REALISE Asia was a quantitative, online questionnairebased survey, which used a similar methodology as REALISE. 5 The questionnaire from REALISE compared asthma symptoms and indicators of acute exacerbations across guideline-defined control levels 7 and treatment types, investigated patients' perceptions of asthma and attitudes toward asthma management, and identified that their sources of information had been cognitively tested and contained many validated elements. Our study's working group, consisting of practicing physicians and respiratory specialists, made revisions to the original questionnaire (permission granted, see Supplementary material), taking into consideration the local context (eg, the use of Weibo in People's Republic of China) and asking the patients what the term "well-controlled asthma" meant to them. A field-test of the questionnaire was carried out with ten respondents per country prior to the survey. The results were analyzed, and minor amendments to the questionnaire were made for clarity.
survey population
Recruitment was done via a simple random sample of individuals aged 18-50 years from validated consumer panels 12 in People's Republic of China, Hong Kong, Indonesia, Korea, Malaysia, Philippines, Singapore, and Taiwan. Email invites were sent to these individuals between December 2013 and March 2014 asking them to complete a 30-minute online questionnaire (Supplementary material). As there were no hospital/physician associations or referrals, approvals from institutional review boards were not required. The survey was conducted according to the International Chamber of Commerce/ European Society for Opinion and Market Research (ICC/ESOMAR) International Code on Market and Social Research, 13 which sets out ethical principles for the conduct of market research. Patient informed consent was also obtained from each respondent.
The sample size was based on factors, including population size and implementation cost, within 4%-8% error margin at 95% confidence level.
14 The inclusion criteria were patients aged 18-50 years who were diagnosed with asthma, given greater than or equal to two asthma-related prescriptions in the past 2 years (to ensure that patients have active asthma), and had used social media. Respondents who were employed; had relatives employed in the health care, pharmaceutical, advertising, or market research industries; or had taken part in health care-related market research in the past 3 months were excluded.
Data collection
Respondents were allowed to answer the questionnaire once. Data quality checks included confirming responses and weeding out unusual or illogical answers. Questions were designed to sieve out inconsistent or fraudulent responses, and some items were repeated for consistency and verification. Responses in the local language were interpreted and translated back to English. The working group reviewed and approved the translated materials.
Data analysis
Responses to the questionnaire were analyzed for the total eligible population. Answers relating to asthma symptoms and indicators of acute exacerbations were analyzed by 
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A new language for asthma control GINA-defined control levels 7 and treatment type. Symptoms assessed were daytime asthma symptoms, night waking, activity limitation due to asthma, and reliever use 15 during the past 7 days, and indicators were corticosteroids and antibiotics use, days off work, emergency department (ED) admissions, and hospitalizations. Perceptions assessed were asthma control (controlled/uncontrolled) and seriousness and concern of disease (on a 4-point scale). Attitudes were assessed on the patient's agreement (on a 4-point scale) to statements on asthma. Patient's views (in text) of asthma control were categorized by key messages and information sources by the frequency of selection. Tests of statistical significance were performed with Fisher's exact test. 16 
Results

Demographics and clinical characteristics
A total of 71,002 individuals started the questionnaire. Of them, 49,409 who did not meet the inclusion criteria and 18,672 who did not complete the survey were excluded. The most common exclusion reason was that they did not have asthma (75.6%, n=37,505). Among the eligible respondents, 454 failed data quality checks and were excluded. The final analysis set contained 2,467 patients ( Figure 1 ). The largest group was from People's Republic of China (32.4%), followed by South Korea (20.3%) and Taiwan (12.2%). Table 1 presents their demographic and clinical characteristics. The mean age of asthma patients was 34.2 (±7.4) years. Both sexes were equally represented. They had been diagnosed with asthma for 12.5 (±9.7) years. Nine of ten patients were taking medication for their asthma, and 35.3% of them used a reliever and 16.5% used a controller. About 11.5% of the patients were current smokers.
Asthma control and symptoms
Using the GINA-defined criteria, 7 17.8% (440), 32.5% (802), and 49.7% (1,225) of patients had controlled, partially controlled, and uncontrolled asthma, respectively ( Table 2 ). In the week before the survey, 38.2% of patients experienced asthma symptoms for .2 days, 64.2% indicated that symptoms interfered with their normal activities, and 71.2% had night awakenings due to asthma. Of the 1,887 patients who 
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Price et al owned a reliever inhaler, 45.2% used it greater than or equal to two times during the same period. In the year prior to the survey, 38.4% of patients visited the ED and 33.1% were hospitalized for asthma. Most (76.5%) patients required greater than or equal to one course of antibiotics to treat health problems related to asthma and 73.1% had greater than or equal to one course of corticosteroids for worsening asthma during the past year. Two of three patients missed work because of asthma. Patients with controlled asthma also experienced acute exacerbations in the previous year. They were mostly treated with antibiotics (56.1%) or oral corticosteroids (46.8%). Table 3 shows the asthma symptoms and indicators of acute exacerbations by treatment types. Patients who were prescribed reliever-only or controller-only inhalers tended to have less symptoms compared to those on multiple therapies. Similar results were also obtained for the indicators of exacerbations. About four to five of ten patients who were prescribed relievers had used them greater than two times a week.
Asthma symptoms and indicators of exacerbations by treatment types
Patients' perceptions of asthma Figure 2 describes the patients' view of asthma control. Twothirds of patients related control to managing attacks: attacks are controllable with medical help (28.2%), no or reduced attacks (16.3%), prevention of attacks through medicines (10.6%), or lifestyle modification, eg, avoidance of triggers (10.4%). About 24.1% saw it as minimal symptoms or impact on normal activities. Figure 3 relates the patients' perception of asthma to their condition as defined by the GINA 7 guidelines. 
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A new language for asthma control Asthma condition is controllable/can be controlled with medical help "I directly ask for help when the symptoms arise, either by using medication or by getting medical treatment from medical team". "That I have sufficient medication in the event of an attack and I am confident in the medication I take".
"Low frequency of relapses (attack) within a month, or the condition can be controlled very quickly using medication during relapses".
"In case of attack, I can manage it by medication" "Being able to "ride out" the attack without medication by controlling my breathing"
"Do exercise daily and take healthy food". "I can cope with asthma provided that I do not make contact with the stimulants and I maintain a healthy lifestyle" "Still live an active life and act normal the way other healthy people do". When asked about their asthma, 89.1% of patients felt that it was under control and 81.5% felt that it was not serious (Table 4) . Patients with uncontrolled asthma also felt no differently (cf, 81.6% and 70.1%, respectively), but were more concerned about their condition than those with controlled asthma (58.7% vs 21.6%). For patients who experienced acute exacerbations requiring a visit to the ED or hospitalization, a smaller percentage compared to the overall population felt that their asthma was under control (83.5%, 82.5% vs 89.1%) or not serious (70.2%, 66.8% vs 81.5%). A higher percentage of them were also concerned about their asthma (60.3%, 63.3% vs 45.6%). Table 5 shows the patient's attitudes toward asthma in daily life. They felt that they should fit in with people around them (88.7%) and did not want to be labeled as sick (85.0%) or 
Attitudes toward asthma and its management
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A new language for asthma control think about their asthma (70.0%). They also trusted their doctors and followed their instructions to manage their condition (86.8%). These percentages were similar across all the control levels. More patients with well-controlled asthma felt healthy and fit compared to those with uncontrolled asthma (82.0% vs 62.4%, P,0.01). They viewed their condition as different from sufferers with uncontrolled asthma (72.0% vs 60.7%, P,0.01). When asked if they were worried about their condition in 10 years, more patients with uncontrolled asthma agreed compared to patients with controlled asthma (72.0% vs 42.7%, P,0.01).
About half of all patients agreed with statements that having inhalers was embarrassing or a nuisance. Patients with uncontrolled asthma, in particular, felt that it was an embarrassment (62.0%) or nuisance (52.2%) to use an inhaler or even carry one (56.7%) in public.
Attitudes toward controller inhalers
Most patients (52.8%) were aware of the need to use controller inhaler regularly to control their asthma. When asked about their controller inhalers, 19.9% of patients identified them correctly, 31.3% incorrectly, and the rest did not know. Figure 4 shows the frequency of controller inhaler usage in the week prior to the survey. About 13.9% of patients used it daily and 42.8% used it on some days. Of those who answered correctly, 30.0% used them daily compared to 16.7% who could not (P,0.01). The 14.1% of patients who correctly named their controller inhalers had controlled asthma compared to 6.0% of those who could not (P,0.01, Figure 5 ).
sources of asthma information
Nine-tenths of patients actively looked for information about asthma and one-third, at least once a week. Patients searched for information on asthma attack prevention, what makes asthma worse or can trigger attacks and what to do in an event of an asthma attack. Figure 6 shows the sources of asthma information. Online sources and health care professionals (HCPs) were cited in 42.5% and 38.4% of the responses, respectively. Health care professionals were considered trustworthy information sources and consisted of respiratory specialists (57.3% of patients), family physicians/general practitioners (37.6%), and internal medicine specialists (33.2%). Other sources of information include health websites (38.6%), online health forums (35.9%), friends (32.2%), and family (29.5%).
Discussion
Our study showed that patient knowledge of asthma control and inhaler medication is low. Our patients viewed asthma control as being able to manage or relieve the exacerbations or attacks instead of preventing them. This was seen in the way they understood the concept of asthma control and reflected in 
101
A new language for asthma control their medication usage: reliever users outnumbered controller users by 2:1. In addition, about half the reliever users had a high frequency of use (greater than two times per week). This suggested that the level of control could have been underestimated and the prescribed therapy was inadequate, not taken, or not appropriate. Asthma management was crisis-oriented through the widespread use of oral corticosteroids and antibiotics and emergency care -ED visits or hospitalization. Despite this, most patients held on to the belief that their asthma was not serious and under control. As a result, the level of control remained low and ,one-fifth of our patients achieved GINA-defined controlled asthma. Many patients were concerned about their condition, especially those who had experienced acute exacerbations. The knowledge of controller inhalers was low, and only one-fifth of users could correctly identify their medication. Although they understood the preventive value of the inhaler and those who use it required the least hospitalizations or ED visits, many did not use it daily citing embarrassment and nuisance as reasons for not using them. Addressing these issues could improve treatment adherence as patients who correctly identified their inhaler medication had better asthma control.
Many patients expressed confidence in their HCPs and followed their instructions. HCPs are, thus, well placed to help their patients resolve issues about their disease and its management. A study of patient-physician communication and patients' knowledge about asthma in Italy 17 showed that 28.5% of general practitioners did not encourage patients to express doubts, expectations, or concerns and that 36.9% were unlikely to involve the patient in asthma management. Our patients used social media and searched online for information, and their enquiries revealed a desire to self-manage their asthma. The Internet provides an excellent opportunity to augment the delivery of asthma management information through online channels, such as search engines, healthrelated websites, and health forums.
Our survey relied on patients' responses to the online questionnaire. These responses could not be clinically verified, and some patients might have inaccurately recalled certain events. Our respondents were patients who used social media and may not represent the cross-section of the asthmatic population. Compared to other Asian studies [9] [10] [11] that utilized face-to-face or phone interviews, the lower average age (34.2 years vs 40.5-45.0 years) and smaller female representation (46.3% vs 54.0%-57.5%) reflect the younger, male-predominant online population of our patients. REALISE 5 patients also had a lower average age. However, clinical findings such as daytime symptoms 
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Price et al or seeking help at EDs was consistent with these studies (38.2% vs 23.9%-57.8% and 38.4% vs 40.0%-42.7%, respectively). 5, [9] [10] [11] Our study population and that of REALISE 5 also had higher percentages of patients with controlled asthma (18%-20% vs 2%-3%). [7] [8] [9] These two populations could have better access to asthma information and put them at an advantage compared to the general asthma population. Segmentation of patients could provide further insights of their attitudes on asthma control, given the disparities in socioeconomic status of patients in different countries of multicultural Asia.
implications of results for asthma management policy and practice
Our study revealed a crisis-oriented approach to asthma management: high reliever and oral corticosteroid use, ED visits, and hospitalizations. This mind-set is similarly evident in how patients understand the concept of well-controlled asthma. Asthma management strategies need to evolve from relief to prevention. As patients are not always able to understand asthma control, HCPs are best positioned to educate patients on their condition, address the perception discrepancy, help patients overcome their anxieties, and influence their attitudes toward treatment. Patient education, however, needs a new language to promote a shared understanding of asthma control between patients and physicians.
Conclusion
Patients consistently overestimate their level of asthma control rather than what their clinical symptoms suggest. This discrepancy may be due to the patients' perception that asthma control is about managing exacerbations instead of achieving a predefined level of symptom control. Patients also expressed concern about their asthma and sought information on how to manage their condition. Interventions to address patients' perception of asthma control and attitudes toward the use of controller inhalers can leverage on their confidence in their HCPs and desire for better self-management. A new language to communicate the guideline-defined asthma control and promote the preventive use of controller medication is needed.
